The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Diabetes and Risk of Parkinson’s Disease
Open accessAbstract
OBJECTIVE: To investigate the relationship between diabetes and future risk of Parkinson’s disease (PD) among older U.S. adults. RESEARCH DESIGN AND METHODS: A prospective study of self-reported diabetes in 1995 and 1996 in relation to PD diagnosed after 1995 among 288,662 participants of the National Institutes of Health-AARP Diet and Health Study. Multivariate odds ratio (OR) and 95% CI were derived from logistic regression models. RESULTS: A total of 1,565 participants with PD diagnosed after 1995 were included in the analysis. After adjustment for potential confounders, PD risk was ∼40% higher (OR = 1.41 [95% CI 1.20–1.66]) among diabetic patients than among participants without diabetes. Further analysis showed that the risk elevation was largely limited to individuals who had diabetes for more than 10 years at the time of baseline survey (1.75 [1.36–2.25]). The association with diabetes was seen for both participants with PD diagnosed between 1995 and 1999 and participants with PD diagnosed after 2000. In addition, similar results were obtained after excluding participants with stroke, heart disease, cancers, or poor or fair health status and in subgroup analyses by age, sex, smoking status, and coffee consumption. CONCLUSIONS: This large study showed that diabetes was associated with a higher future risk of PD and the nature of this association warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.005 · Cited by 1,234
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care · doi:10.2337/dc06-0062 · Cited by 1,210 · cited 1×
“have diabetes (1), in part because of high prevalence of inactive lifestyle and obesity.”
BackgroundType 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · cited 2×
“Over the past decade, diabetes has been reported to be associated with increased risk of dementia (3) and Alzheimer’s disease (4), suggesting a potential role of diabetes or insulin dysregulation in neurodegeneration.”
Background(2008) · PsycEXTRA Dataset · doi:10.1037/e549122009-001 · Cited by 862
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783
Design and Serendipity in Establishing a Large Cohort with Wide Dietary Intake Distributions
Schatzkin, A., Subar, A. F., Thompson, F. E., Harlan, L. C., Tangrea, J., Hollenbeck, A. R., Hurwitz, P. E., Coyle, L., Schussler, N., Michaud, D. S., et al. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.12.1119 · Cited by 609
Self-citationType 2 Diabetes and the Risk of Parkinson's Disease
Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., & Tuomilehto, J. (2007) · Diabetes Care · doi:10.2337/dc06-2011 · Cited by 466
UNGER, J., LIVINGSTON, J., & MOSS, A. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90015-s · Cited by 404
Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease
Chen, H., O'Reilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm260 · Cited by 317
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy
American Diabetes Association, & American Academy of Neurology (1988) · Diabetes Care · doi:10.2337/diacare.11.7.592 · Cited by 286
The Relationship Between Diabetes Mellitus and Parkinson'S Disease
Sandyk, R. (1993) · International Journal of Neuroscience · doi:10.3109/00207459309003322 · Cited by 243
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Simon, K. C., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000271883.45010.8a · Cited by 231
Self-citationSmoking duration, intensity, and risk of Parkinson disease
Chen, H., Huang, X., Guo, X., Mailman, R. B., Park, Y., Kamel, F., Umbach, D. M., Xu, Q., Hollenbeck, A., Schatzkin, A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d55f38 · Cited by 223
Self-citationPPAR‐gamma‐mediated neuroprotection in a chronic mouse model of Parkinson’s disease
Schintu, N., Frau, L., Ibba, M., Caboni, P., Garau, A., Carboni, E., & Carta, A. R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06657.x · Cited by 200
Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients: A Case-Control Study
Scigliano, G., Musicco, M., Soliveri, P., Piccolo, I., Ronchetti, G., & Girotti, F. (2006) · Stroke · doi:10.1161/01.str.0000217384.03237.9c · Cited by 182
Obesity, Metabolic Syndrome, and Type 2 Diabetes: Inflammatory Basis of Glucose Metabolic Disorders
Pradhan, A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00354.x · Cited by 175
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Driver, J. A., Smith, A., Buring, J. E., Gaziano, J. M., Kurth, T., & Logroscino, G. (2008) · Diabetes Care · doi:10.2337/dc08-0688 · Cited by 168
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.002 · Cited by 154
Obesity, Metabolic Syndrome, and Type 2 Diabetes: Inflammatory Basis of Glucose Metabolic Disorders
Pradhan, A. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.dec.s152-s156 · Cited by 145
Diabetes, Oxidative Stress, Nitric Oxide and Mitochondria Function
Friederich, M., Hansell, P., & Palm, F. (2009) · Current Diabetes Reviews · doi:10.2174/157339909788166800 · Cited by 135
Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk
Powers, K. M., Smith‐Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.09.004 · Cited by 99
Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes
Scranton, R. E., & Cincotta, A. H. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903501544 · Cited by 96
Diabetes in Patients With Idiopathic Parkinson's Disease
Becker, C., Brobert, G., Johansson, S., Jick, S. S., & Meier, C. R. (2008) · Diabetes Care · doi:10.2337/dc08-0479 · Cited by 81
Diabetes preceding Parkinson's disease onset. A case–control study
D’Amelio, M., Ragonese, P., Callari, G., Benedetto, N. D., Palmeri, B., Terruso, V., Salemi, G., Famoso, G., Aridon, P., & Savettieri, G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.013 · Cited by 76
Cited by
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,825
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779
Insulin resistance in brain alters dopamine turnover and causes behavioral disorders
Kleinridders, A., Cai, W., Cappellucci, L., Ghazarian, A., Collins, W. R., Vienberg, S. G., Pothos, E. N., & Kahn, C. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500877112 · Cited by 486
Insulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 328
Metadata
- Authors
- Xu, Q., Park, Y., Huang, X., Hollenbeck, A., Blair, A., Schatzkin, A., & Chen, H.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-03-21
- Volume
- 34
- Issue
- 4
- Pages
- 910-915
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2090012352
- Cited by
- 271
- References
- 26
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.